2-氨基-N,3-二甲基-5-硫氰基苯甲酰胺的合成

本文报道一种未见文献报道的化合物2-氨基-N,3-二甲基-5-硫氰基苯甲酰胺的合成。从3-甲基氨茴酸出发,用两种不同方法得到2-氨基-N,3-二甲基苯甲酰胺,随后在0-5℃条件下与硫氰酸钠与溴素的混合物反应,高收率地得到2-氨基-N,3-二甲基5-硫氰基-苯甲酰胺。该化合物经核磁共振氢谱、碳谱、红外光谱和高分辨质谱表征和确认。同时考察了硫氰酸钠与溴素的用量及比例对反应产物纯度和收率的影响,发现2-氨基-N,3-二甲基苯甲酰胺、硫氰酸钠与溴素的摩尔比为1∶4∶2时,能以好的分离收率得到目标产物。     

6-卤代咪唑并[1,2-a]吡嗪-3-甲酰胺的简便合成

6-卤代咪唑并[1,2-a]吡嗪-3-甲酰胺是一类重要的抗癌新药中间体,广泛应用于淋巴癌、肺癌、皮肤癌等癌症新药的研发。以2-氨基吡嗪为起始原料,与N-卤代丁二酰亚胺发生卤代反应,与N,N-二甲基甲酰胺二甲基缩醛制备亚胺化合物,再和溴乙酸乙酯缩合成环制备6-卤代咪唑并[1,2-a]吡嗪-3-甲酸乙酯,再与氨水氨解共4步反应合成6-卤代咪唑并[1,2-a]吡嗪-3-甲酰胺,总收率为50.7～54.2%。产物结构经IR、~1H NMR、~(13)C NMR、元素分析进行了表征。此合成路线具有原料易得、操作简单、成本低廉、产率较高、避免柱层析分离纯化、更适合工业化放大生产的特点。     

2-乙氧基-N-(4-甲基-2-丙基-1H-咪唑基-1)-苯甲酰胺的合成

2-乙氧基苯甲酸甲酯与水合肼发生肼解反应生成2-甲氧基苯甲酰肼(1);1与丁亚氨酸乙酯盐酸盐进行二次肼解反应制得2-乙氧基-N'-(1-亚胺丁基)苯甲酰肼盐酸盐(3);3与氯丙酮环化合成了2-乙氧基-N-(4-甲基-2-丙基-1H-咪唑基-1-)苯甲酰胺(合成伐地那非的关键中间体),总收率48%,其结构经1H NMR和MS确证.     

2-氨基-4-甲氧基氯代苯甲酸的合成研究

以2-氨基-4-甲氧基苯甲酸甲酯为原料,通过氯代反应,再分别通过酯水解反应得到化合物2-氨基-5-氯-4-甲氧基苯甲酸和2-氨基-3-氯-4-甲氧基苯甲酸。其中间体及产物结构经~1H NMR、~(13)C NMR和ESI-MS确证,并考察了最佳氯代反应条件。结果表明:物料配比为n(2-氨基-4-甲氧基苯甲酸甲酯)∶n(NCS)=1∶1. 2,反应溶剂为N,N-二甲基甲酰胺,反应时间为16 h,两种氯代产物2-氨基-5-氯-4-甲氧基苯甲酸甲酯和2-氨基-3-氯-4-甲氧基苯甲酸甲酯收率分别为47%和39%。     

红紫素-18的卤化反应及其二氢卟吩类衍生物的合成

从红紫素-18甲酯开始,通过对其3-位乙烯基和20-meso-位的亲电加成和亲电取代反应,区域选择性地给出相应的氯代或者溴代产物.红紫素-18甲酯与重氮甲烷的1,3偶极环加成反应生成C(3)-吡唑啉基取代的红紫素-18,继续与N-溴代丁二酰亚胺(NBS)和N-氯代丁二酰亚胺(NCS)进行亲电取代反应,生成相应的卤代吡唑啉基取代二氢卟吩.3-吡唑啉基红紫素-18热裂解后的卤代反应则给出3-环丙基-20-卤代二氢卟吩.选择脱镁叶绿酸-a甲酯为另一起始反应物,通过C(3)-乙烯基和E-环结构的一系列化学转换和20-meso-位的溴代反应,区域选择性地得到20-溴代红紫素-18衍生物.新报道的标题化合物均经UV,IR,1H NMR及元素分析证明其结构.     

2-氨基-5-氰基-N,3-二甲基苯甲酰胺合成方法改进

从3-甲基氨茴酸出发,用氯化亚砜取代光气及其衍生物,通过2种不同的反应途径,高收率地合成了氰虫酰胺的关键中间体2-氨基-5-氰基-N,3-二甲基苯甲酰胺(1)。考察了不同形态的甲胺、反应温度、溶剂以及不同的吡啶衍生物对反应的影响。     

6-溴(氯)-2-氯甲基-3-喹啉甲酸乙酯的合成方法研究

以邻硝基苯甲醛为起始原料,经还原和氨基保护合成2-乙酰胺基苯甲醛(1)。应用环境友好的聚乙二醇-400为溶剂,以N-卤代丁二酰亚胺为卤代试剂对化合物2-乙酰胺基苯甲醛(1)进行卤代,制备了5-溴(氯)-2-乙酰胺基苯甲醛(2a,2b)。在三甲基氯硅烷(TMSCl)催化作用下,5-溴(氯)-2-乙酰胺基苯甲醛(2a,2b)与4-氯乙酰乙酸乙酯发生Friedlnder缩合反应,合成目标产物6-溴(氯)-2-氯甲基-3-喹啉甲酸乙酯(3a,3b)。其中2a,2b,3a,3b的结构经IR、1H NMR、13C NMR、MS得以确定。     

2-甲基-6-(3-甲基-2-丁烯基)对苯二醌的合成

以邻甲基苯酚为原料,与1-氯-2-甲基-2-丁烯反应生成2-甲基-6-(3-甲基-2-丁烯基)苯酚,然后催化氧化得到目标产物2-甲基-6-(3-甲基-2-丁烯基)对苯二醌。该合成路线简单,易于操作,最终收率51%。     

BPB-Ni(II)-Ala复合物法不对称合成双-α-甲基氨基酸

以2-N-(N’-苄基脯氨酰)-氨基二苯甲酮-镍(II)-丙基酸复合物为手性助剂, 与不同碳链长度的二溴烷烃反应制备 双-α-甲基氨基酸. 其中, BPB-Ni(II)-Ala复合物与1,3-二溴丙烷发生取代-消除反应后生成烯丙基取代复合物中间体, 产率高达90%, 水解生成2-甲基-2-氨基-4-烯-戊酸; 与1,4-二溴丁烷、1,5-二溴戊烷、1,6-二溴己烷可以实现双取代反应, 但所得的主要产物为单取代的BPB-Ni(II)-Ala复合物, 双-α-甲基氨基酸复合物中间体收率分别为38%, 36%, 45%, 经过水解后生成相应的双-α-甲基氨基酸, 分别为2,7-二氨基-2,7-二甲基辛二酸、2,8-二氨基-2,8-二甲基壬二酸、2,9-二氨基-2,9-二甲基癸二酸. 手性助剂2-N-(N’-苄基脯氨酰)-氨基二苯甲酮的回收率可高达95%.     

BPB-Ni(Ⅱ)-Ala复合物法不对称合成双-α-甲基氨基酸

以2-N-(N'-苄基脯氨酰)-氨基二苯甲酮-镍(Ⅱ)-丙基酸复合物为手性助剂,与不同碳链长度的二溴烷烃反应制备双-α-甲基氨基酸.其中,BPB-Ni(Ⅱ)-Ala复合物与1,3-二溴丙烷发生取代-消除反应后生成烯丙基取代复合物中间体,产率高达90%,水解生成2-甲基-2-氨基-4-烯-戊酸;与1,4-二溴丁烷、1,5-二溴戊烷、1,6-二溴己烷可以实现双取代反应,但所得的主要产物为单取代的BPB-Ni(Ⅱ)-Ala复合物,双-α-甲基氨基酸复合物中间体收率分别为38%,36%,45%,经过水解后生成相应的双-α-甲基氨基酸,分别为2,7-二氨基-2,7-二甲基辛二酸、2,8-二氨基-2,8-二甲基壬二酸、2,9-二氨基-2,9-二甲基癸二酸.手性助剂2-N-(N'-苄基脯氨酰)-氨基二苯甲酮的回收率可高达95%.     

(S)-(4-溴-2-甲苯)(3-甲基吗啉)甲酮的合成

以(S)-2-氨基丙醇和氯乙酰氯为起始原料,经酰化和环合反应制得(S)-5-甲基吗啉-3-酮（4）; 4经还原制得(S)-3-甲基吗啉(5); 5与4-溴-2-甲基苯甲酸酰化缩合合成了(S)-(4-溴2-甲基苯基)(3-甲基吗啉)-甲酮,总收率57%,其结构经¹H NMR 和 ¹³C NMR确证。     

Thermodynamic study of the sublimation of six aminomethylbenzoic acids

The Knudsen mass-loss effusion technique was used to measure the vapour pressures at different temperatures of the following substituted benzoic acids: 2-amino-3-methylbenzoic acid at T between 343.16 K and 357.17 K; 2-amino-5-methylbenzoic acid at T between 345.15 K and 361.16 K; 2-amino-6-methylbenzoic acid at T between 339.17 K and 355.15 K; 3-amino-2-methylbenzoic acid at T between 367.16 K and 381.22 K; 3-amino-4-methylbenzoic acid at T between 363.18 K and 377.16 K; and 4-amino-3-methylbenzoic acid at T between 367.17 K and 383.14 K. The standard, p⁰ =  10⁵Pa, molar enthalpies, entropies, and Gibbs energies of sublimation at T =  298.15 K were derived from the temperature dependence of the vapour pressure using estimated values for the heat capacity differences between the gas and the crystal phases of the studied compounds.     

Thiocarbamoylation of amine-containing compounds

The reaction of 3-amino-4-methylbenzoic acid with tetramethylthiuram disulfide in DMF afforded 3-N,N-dimethylthioureido-4-methylbenzoic acid. Thermolysis or treatment of the latter with acidic reagents resulted in elimination of dimethylamine to form 3-isothiocyanato-4-methylbenzoic acid whose reaction with hydrazine yielded substituted thiosemicarbazide. The reactions of the latter with aldehydes and ketones gave thiosemicabazones, and its reaction with tetramethylthiuram disulfide afforded 3-(2-mercapto-1,3,4-thiadiazol-5-ylamino)-4-methylbenzoic acid. Translated fromIzvestiya Akademii Nauk. Seriya Khimicheskaya, No. 4, pp. 743–746, April, 1999.     

A new pathway via intermediate 4-amino-3-fluorophenol for the synthesis of regorafenib

A practical synthetic route to regorafenib, in which the target compound was obtained via a 10-step synthesis starting from 2-picolinic acid, 4-chloro-3-(trifluoromethyl)aniline, and 3-fluorophenol, is reported. Crucial to the strategy is the preparation of 4-amino-3-fluorophenol via Fries and Beckman rearrangements using an economical and practical protocol. The main advantages of the route include inexpensive starting materials and an acceptable overall yield. A scale-up experiment was carried out to provide regorafenib with 99.96% purity in 46.5% total yield.     

An improved synthesis of the potent and selective γ-glutamyl transpeptidase inhibitor GGsTop together with an inhibitory activity evaluation of its potential hydrolysis products

A previously reported synthetic route to 2-amino-4-{[3-(carboxymethyl)phenoxy](methoxy)phosphoryl}butanoic acid (GGsTop), a potent, highly selective, non-toxic, and irreversible inhibitor of γ-glutamyl transpeptidase (GGT) was substantially improved. This route furnishes GGsTop in four steps with an overall yield of 32% from inexpensive starting materials, i.e., the yield is increased approximately sixfold relative to the previous protocol. The synthesis and inhibitory activity evaluation of potential hydrolysis products of GGsTop clearly demonstrated that GGsTop is the active inhibitor, and the conceivable hydrolysis products barely affect the activity of human GGT.     

Analogues of the antibiotic puromycin as potential prodrugs of 3′-amino-3′-deoxythymidine

Condensation of L- and D-3′-amino-2′,3′-dideoxynucleosides 2–5 with N-BOC-protected aminoacids 6 and 13 using dicyclohexylcarbodiimide and N-hydroxysuccinimide in DMF is reported to give the N-BOC-protected acylamino aminonucleosides 7– 9 and 14 in 51–81% yield. After deprotection using trifluoroacetic acid the corresponding unprotected new analogues of puromucin 10–12 and 15 were obtained in 43–56% yield. These compounds did not show any significant antiviral activity using HIV (stain HTLV-III B)-infected MT-4 cells as target system.     

An improved synthesis of butyl 4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]-1-piperidineacetate (AU-224).

A new and facile route for the synthesis of the novel gastrointestinal prokinetic butyl 4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]-1-piperidineacetate (1b), which exhibited potent gastro- and colon-prokinetic activities by oral administration without significant side effects, was established. The key intermediate, butyl 4-amino-1-piperidineacetate (16), was prepared from commercially available 4-amino-1-benzylpiperidine (2) in a high yield with four steps. Compound 1b was prepared by condensation of commercially available 4-amino-5-choloro-2-methoxybenzoic acid (7) with 16 in 84% yield. This improved synthetic route was appropriate for large-scale synthesis of 1b.     

Enantioselective synthesis of both enantiomers of the neuroexcitant 2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid (ATPA)

The preparation of both enantiomers of 2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid (ATPA), 1, an analogue of the neuroexcitant 2-amino-3-(3-hydroxy-5-methyl-4-yl) propanoic acid (AMPA) is described. The enantiomerically pure glycine derivative tert-butoxycarbonyl-2-(tert-butyl)-3-methyl-4-oxo-1-imidazolidinecarboxylate (BOC-BMI) was coupled with 4-bromomethyl-2-methoxymethyl-5-tert-butylisoxazolin-3-one 6 to give the intermediates (2R,5R)-8 and (2S,5S)-8. These alkylated products were hydrolyzed under mild conditions to give enantiopure (R)-1 and (S)-1 with e.e.'s in excess of 99% in 33% overall yield.     

基于配合共保护策略合成γ-L-谷氨酰二肽的新方法

提出了一种采用谷氨酸席夫碱Ni(II)配合物共保护L-谷氨酸的α-氨基和α-羧基合成γ-L-谷氨酰二肽的新方法. 首先由手性助剂——2-[N-(N-苄基-脯氨酰)氨基]二苯甲酮(1)、六水合氯化镍和L-谷氨酸反应, 得到谷氨酸席夫碱Ni(II)配合物2, 产率为98.2%; 进而采用二异丙基碳二亚胺(DIC)/1-羟基-苯并三唑(HOBt)复合缩合剂法分别与L-氨基酸3a～3h反应, 得到相应的γ-L-谷氨酰二肽席夫碱Ni(II)配合物4a～4h, 产率为93.1%～99.0%; 最后稀酸水解配合物, 得到γ-L-谷氨酰二肽5a～5h, 产率为73.0%～86.4%, 高收率(92.2%～97.4%)回收手性助剂. 中间产物和终产物的结构经由旋光, 1H NMR, 13C NMR和HRMS表征.     

柠檬醛及中间体的合成

以异戊烯醛和异戊烯醇为原料,经异戊烯酸催化缩醛化反应得到3-甲基-2-丁烯醛二异戊烯基缩醛,再经磷酸二氢铵催化消除反应得到顺/反-异戊二烯基-3-甲基丁二烯醚,并进一步热重排获得柠檬醛。研究了缩醛化反应条件和消除反应条件对转化率的影响。结果表明,以0.3%异戊烯酸为酸性催化剂,70～75℃共沸脱水反应8 h,异戊烯醛的单程转化率达到63%～64%,处理后可得含量为97.5%的3-甲基-2-丁烯醛二异戊烯基缩醛,收率96.8%;以0.2%～0.5%磷酸二氢铵为催化剂,100～130℃,2.66 kPa下反应并及时将反应产物蒸出,处理后得到含量为95.9%的顺/反-异戊二烯基-3-甲基丁二烯醚,收率97.0%。顺/反-异戊二烯基-3-甲基丁二烯醚在120～130℃重排反应1 h,其反应产物柠檬醛含量97.5%,收率90.2%。